Revisión clínica

Published on 4 de junio de 2021 | http://doi.org/10.5867/medwave.2021.05.8202

Update on immunotherapy for renal cancer

Back to article Figure 2.

PD-1/PD-L1 blockade by an anti-PD-1 monoclonal antibody.